NEURALSTEM INC's gross profit margin for the fourth quarter of its fiscal year 2015 has significantly decreased when compared to the same period a year ago. Even though sales decreased, the net income has increased. NEURALSTEM INC has strong liquidity. Currently, the Quick Ratio is 1.88 which shows the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
At the same time, stockholders' equity ("net worth") has significantly decreased by 71.96% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY15||Q4 FY14|
|Net Sales ($mil)||0.0||0.01|
|Net Income ($mil)||-4.77||-5.5|
|Balance Sheet||Q4 FY15||Q4 FY14|
|Cash & Equiv. ($mil)||12.23||27.53|
|Total Assets ($mil)||15.05||29.84|
|Total Debt ($mil)||8.03||8.79|
|Profitability||Q4 FY15||Q4 FY14|
|Gross Profit Margin||-213100.0||-91040.0|
|Return on Assets||-138.91||-75.82|
|Return on Equity||-420.85||-127.71|
|Debt||Q4 FY15||Q4 FY14|
|Share Data||Q4 FY15||Q4 FY14|
|Shares outstanding (mil)||92.01||87.79|
|Div / share||0.0||0.0|
|Book value / share||0.05||0.2|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||158882.0||367483.0|
SELL. This stock’s P/E ratio is negative, making its value useless in the assessment of premium or discount valuation, only displaying that the company has negative earnings per share. Conducting a second comparison, its price-to-book ratio of 12.99 indicates a significant premium versus the S&P 500 average of 2.76 and a premium versus the industry average of 11.60. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, NEURALSTEM INC seems to be trading at a premium to investment alternatives within the industry.
|CUR NM||Peers 205.35||CUR NM||Peers 30.10|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
CUR's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
CUR's P/CF is negative making the measure meaningless.
|CUR NM||Peers 31.38||CUR NA||Peers 1.76|
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.
CUR's ratio is negative making this valuation measure meaningless.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|CUR 12.99||Peers 11.60||CUR 11.54||Peers 32.25|
Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
CUR is trading at a premium to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, CUR is expected to significantly trail its peers on the basis of its earnings growth rate.
|CUR 6440.42||Peers 312.72||CUR -47.37||Peers 53.40|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
CUR is trading at a significant premium to its industry.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
CUR significantly trails its peers on the basis of sales growth
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.